Item 2.02 Results of Operations and Financial Condition.
As previously announced, on
Item 7.01 Regulation FD Disclosure.
The live webcast and a copy of the accompanying presentation materials that will be used at the Conference will be available through the "Investors" page of the Company's website at http://www.bioxceltherapeutics.com.
The information in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
© Edgar Online, source